Weight-loss drugs killed my appetite for life

Sam Altman, the co-founder of OpenAI, which launched ChatGPT, is not overweight. Gay tech billionaires rarely are. Even so, as he explained in a recent interview, he was keen to try a GLP-1, one of those drugs that have revolutionised weight loss in the past five years. You can understand why he was curious. Ozempic

Raccontata daspectator.com